Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Decline in breast cancer mortality: how much is attributable to screening?

Njor SH, Schwartz W, Blichert-Toft M, Lynge E.

J Med Screen. 2015 Mar;22(1):20-7. doi: 10.1177/0969141314563632. Epub 2014 Dec 9.

PMID:
25492943
2.

Overdiagnosis in screening mammography in Denmark: population based cohort study.

Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E.

BMJ. 2013 Feb 26;346:f1064. doi: 10.1136/bmj.f1064.

3.

ONCOPOOL - a European database for 16,944 cases of breast cancer.

Blamey RW, Hornmark-Stenstam B, Ball G, Blichert-Toft M, Cataliotti L, Fourquet A, Gee J, Holli K, Jakesz R, Kerin M, Mansel R, Nicholson R, Pienkowski T, Pinder S, Sundquist M, van de Vijver M, Ellis I.

Eur J Cancer. 2010 Jan;46(1):56-71. doi: 10.1016/j.ejca.2009.09.009. Erratum in: Eur J Cancer. 2010 Jun;46(9):1762.

PMID:
19811907
4.

Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol.

Blichert-Toft M, Nielsen M, Düring M, Møller S, Rank F, Overgaard M, Mouridsen HT.

Acta Oncol. 2008;47(4):672-81. doi: 10.1080/02841860801971439.

PMID:
18465335
5.

Danish Breast Cancer Cooperative Group--DBCG: History, organization, and status of scientific achievements at 30-year anniversary.

Blichert-Toft M, Christiansen P, Mouridsen HT.

Acta Oncol. 2008;47(4):497-505. doi: 10.1080/02841860802068615.

PMID:
18465316
6.

Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.

Grabau D, Jensen MB, Rank F, Blichert-Toft M.

APMIS. 2007 Jul;115(7):828-37.

PMID:
17614850
7.

Guidelines on the standards for the training of specialised health professionals dealing with breast cancer.

Cataliotti L, De Wolf C, Holland R, Marotti L, Perry N, Redmond K, Rosselli Del Turco M, Rijken H, Kearney N, Ellis IO, Di Leo A, Orecchia R, Noel A, Andersson M, Audretsch W, Bjurstam N, Blamey RW, Blichert-Toft M, Bosmans H, Burch A, Bussolati G, Christiaens MR, Colleoni M, Cserni G, Cufer T, Cush S, Damilakis J, Drijkoningen M, Ellis P, Foubert J, Gambaccini M, Gentile E, Guedea F, Hendriks J, Jakesz R, Jassem J, Jereczek-Fossa BA, Laird O, Lartigau E, Mattheiem W, O'higgins N, Pennery E, Rainsbury D, Rutgers E, Smola M, Van Limbergen E, von Smitten K, Wells C, Wilson R; EUSOMA.

Eur J Cancer. 2007 Mar;43(4):660-75. Epub 2007 Feb 5.

PMID:
17276672
8.

Characteristics of the Danish families with multiple endocrine neoplasia type 1.

Jäger AC, Friis-Hansen L, Hansen TV, Eskildsen PC, Sølling K, Knigge U, Hansen CP, Andersen PH, Brixen K, Feldt-Rasmussen U, Kroustrup JP, Mollerup CL, Rehfeld JF, Blichert-Toft M, Nielsen FC.

Mol Cell Endocrinol. 2006 Apr 25;249(1-2):123-32. Epub 2006 Mar 23.

PMID:
16563611
9.

[Breast self-examination].

Blichert-Toft M.

Ugeskr Laeger. 2005 Apr 25;167(17):1871-2. Danish. No abstract available.

PMID:
15929340
10.

A model for determining the effect of mammography service screening.

Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tange UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E.

Acta Oncol. 2005;44(2):120-8.

PMID:
15788290
11.

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.

Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tange UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E.

BMJ. 2005 Jan 29;330(7485):220. Epub 2005 Jan 13.

12.

[Renal stone and primary hyperparathyroidism. Risk of renal stone before and after parathyroidectomy].

Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen PM, Blichert-Toft M.

Ugeskr Laeger. 2004 Oct 11;166(42):3726-8. Danish. No abstract available.

PMID:
15508296
13.

Unsuccessful radioiodine treatment of a non-toxic goiter: a case report.

Hartoft-Nielsen ML, Rasmussen AK, Friis E, Blichert-Toft M, Buhl T, Hesse B, Feldt-Rasmussen U.

Basic Clin Pharmacol Toxicol. 2004 Aug;95(2):72-5.

14.

Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma.

Kroman N, Holtveg H, Wohlfahrt J, Jensen MB, Mouridsen HT, Blichert-Toft M, Melbye M.

Cancer. 2004 Feb 15;100(4):688-93.

15.

Immunohistochemical assessment of oestrogen and progesterone receptors: correlations with the DCC method and clinical outcome in primary breast cancer patients.

Grabau DA, Thorpe SM, Knoop A, Vach W, Schrøder HD, Blichert-Toft M, Al-Suliman NN, Graversen HP, Rose C.

Breast. 2000 Aug;9(4):208-17.

PMID:
14731996
16.

[Regional function in thyroid surgery. Assessment of the specialty function and surgical risk factors].

Friis E, Mollerup CL, Blichert-Toft M.

Ugeskr Laeger. 2003 Jul 21;165(30):2958-62. Danish.

PMID:
12926198
17.

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.

Celis JE, Gromov P, Gromova I, Moreira JM, Cabezón T, Ambartsumian N, Grigorian M, Lukanidin E, Thor Straten P, Guldberg P, Bartkova J, Bartek J, Lukas J, Lukas C, Lykkesfeldt A, Jäättelä M, Roepstorff P, Bolund L, Ørntoft T, Brünner N, Overgaard J, Sandelin K, Blichert-Toft M, Mouridsen H, Rank FE.

Mol Cell Proteomics. 2003 Jun;2(6):369-77. Epub 2003 Jun 25.

18.

Cardiovascular events before and after surgery for primary hyperparathyroidism.

Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L.

World J Surg. 2003 Feb;27(2):216-22.

PMID:
12616440
19.

Clinical impact of introduction of mammography screening in a non-screening country with special reference to the Copenhagen service mammography screening programme.

Tange UB, Jensen MB, Vejborg IM, Rank FE, Blichert-Toft M, Mouridsen HT, Lynge E.

Scand J Surg. 2002;91(3):293-303. Review. No abstract available.

PMID:
12449474
20.

The specialist breast unit and breast surgery as a specialty.

Blichert-Toft M, Kroman N.

Scand J Surg. 2002;91(3):227-31. Review. No abstract available.

PMID:
12449463
21.

Aspects of breast surgery.

Blichert-Toft M, von Smitten K.

Scand J Surg. 2002;91(3):219, 221. No abstract available.

PMID:
12449461
22.

Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.

Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M.

BMJ. 2002 Oct 12;325(7368):807.

23.

Cosmetic outcome and breast morbidity in breast-conserving treatment--results from the Danish DBCG-82TM national randomized trial in breast cancer.

Johansen J, Overgaard J, Rose C, Engelholm SA, Gadeberg CC, Kjaer M, Kamby C, Juul-Christensen J, Blichert-Toft M, Overgaard M; Danish Breast Cancer Cooperative Group (DBCG) and the DBCG Radiotherapy Committee.

Acta Oncol. 2002;41(4):369-80.

PMID:
12234030
24.

[Breast cancer].

Blichert-Toft M, Ejlertsen B, Mouridsen H, Overgaard M.

Ugeskr Laeger. 2002 Jun 3;164(23):3023-6. Danish. No abstract available.

PMID:
12082852
25.

[Mammography screening in the county of Copenhagen. Results of the first three screening rounds].

Tange UB, Hirsch FR, Jensen MB, Olsen AH, Blichert-Toft M, Rank FE, Vejborg IM, Mouridsen H, Lynge E.

Ugeskr Laeger. 2002 Feb 18;164(8):1048-52. Danish.

PMID:
11894707
26.

[Mammographic screening in the county of Copenhagen. Clinical consequences of the first three screening rounds].

Tange UB, Hirsch FR, Jensen MB, Olsen AH, Blichert-Toft M, Rank FE, Vejborg IM, Mouridsen H, Lynge E.

Ugeskr Laeger. 2002 Feb 18;164(8):1036-40. Danish.

PMID:
11894704
27.

[Mammographic screening in the municipality of Copenhagen 1991-1997. Evaluation of the preoperative assessment].

Christensen LB, Rank FE, Blichert-Toft M, Christiansen T, Jørgensen T, Dunn S, Jensen LB, Vejborg IM, Tange UB, Mouridsen H, Lynge E.

Ugeskr Laeger. 2002 Jan 7;164(2):191-5. Danish.

PMID:
11831088
28.

[Cohort study of fracture risk before and after surgery of primary hyperparathyroidism].

Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen PM, Blichert-Toft M, Mosekilde L.

Ugeskr Laeger. 2001 Sep 3;163(36):4875-8. Danish.

PMID:
11571864
29.

[TPO immunostaining of the solitary, cold thyroid nodules].

Lange M, Blichert-Toft M, Christensen LH, Brandt M, Sneppen SB, Ravnsbaek J, Mollerup CL, Strange L, Jensen F, Kirkegaard J, Hansen HS, Sørensen SS, Feldt-Rasmussen UF.

Ugeskr Laeger. 2001 Aug 6;163(32):4198-201. Danish.

PMID:
11510238
30.

[Radioiodine treatment of non-toxic goiter].

Blichert-Toft M.

Ugeskr Laeger. 2001 Jul 2;163(27):3820-1. Danish. No abstract available.

PMID:
11467001
31.

[Untreated breast cancer--a myth?].

Blichert-Toft M.

Ugeskr Laeger. 2001 May 14;163(20):2761. Danish. No abstract available.

PMID:
11374208
32.

[Concerning evidence-based surgery].

Blichert-Toft M.

Ugeskr Laeger. 2001 Mar 5;163(10):1450. Danish. No abstract available.

PMID:
11257757
33.

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.

Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, van Tienhoven G, Andersen KW, Sylvester RJ, van Dongen JA; Danish Breast Cancer Cooperative Group. Breast Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.

J Clin Oncol. 2001 Mar 15;19(6):1688-97. Erratum in: J Clin Oncol 2001 May 1;19(9):2583.

PMID:
11250998
34.

[Breast conserving surgery in breast cancer].

Kroman NT, Blichert-Toft M.

Ugeskr Laeger. 2001 Feb 5;163(6):780. Danish. No abstract available.

PMID:
11228809
35.

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.

Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA.

Breast Cancer Res Treat. 2000 Aug;62(3):197-210.

PMID:
11072784
36.

[Marginal hyperparathyroidism. A diagnostic and therapeutic dilemma].

Blichert-Toft M.

Ugeskr Laeger. 2000 Sep 11;162(37):4907. Danish. No abstract available.

PMID:
11002736
37.

Treatment of morbidity associated with the management of the axilla in breast-conserving therapy.

Johansen J, Overgaard J, Blichert-Toft M, Overgaard M.

Acta Oncol. 2000;39(3):349-54.

PMID:
10987232
40.

Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L.

BMJ. 2000 Sep 9;321(7261):598-602.

41.

Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule.

Christensen L, Blichert-Toft M, Brandt M, Lange M, Sneppen SB, Ravnsbaek J, Mollerup CL, Strange L, Jensen F, Kirkegaard J, Sand Hansen H, Sørensen SS, Feldt-Rasmussen U.

Clin Endocrinol (Oxf). 2000 Aug;53(2):161-9.

PMID:
10931096
42.

Thyroperoxidase immunostaining in evaluation of thyroid nodules.

Lange M, Feldt-Rasmussen U, Christensen L, Blichert-Toft M.

Clin Endocrinol (Oxf). 2000 Jun;52(6):797. No abstract available.

PMID:
10848889
43.

[Primary breast reconstruction in connection with mastectomy for breast cancer. Indication, procedure and immediate surgical results].

Elberg JJ, Mollerup CL, Dahlstrøm KK, Ravnsbaek JD, Drzewiecki KT, Rank FE, Blichert-Toft M.

Ugeskr Laeger. 2000 May 1;162(18):2550-3. Danish.

PMID:
10846953
44.

A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.

Zimmermann-Belsing T, Christensen L, Hansen HS, Kirkegaard J, Blichert-Toft M, Feldt-Rasmussen U.

Thyroid. 2000 Mar;10(3):275-8.

PMID:
10779143
45.

[The solitary thyroid nodule and the TPO-immunostaining. The Danish Society of Surgery].

Blichert-Toft M.

Ugeskr Laeger. 2000 Mar 20;162(12):1718. Danish. No abstract available.

PMID:
10745665
46.

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT.

Lancet. 1999 May 15;353(9165):1641-8.

PMID:
10335782
47.

[Serum thyroglobulin compared with ultrasonically detected recurrent goiter].

Hartoft-Nielsen ML, Date J, Feldt-Rasmussen UF, Blichert-Toft M, Hegedüs L.

Ugeskr Laeger. 1999 Apr 19;161(16):2352-7. Danish.

PMID:
10235039
48.

["The sentinel node"--a new surgical principle].

Blichert-Toft M.

Ugeskr Laeger. 1999 Apr 19;161(16):2339. Danish. No abstract available.

PMID:
10235035
49.

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.

van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F, Sylvester R, Fentiman IS, van der Schueren E, van Zijl K, Blichert-Toft M, Bartelink H, van Dongen JA.

Eur J Cancer. 1999 Jan;35(1):32-8.

PMID:
10211085
50.

[One more time! Treatment of borderline primary hyperparathyroidism].

Mollerup CL, Blichert-Toft M.

Ugeskr Laeger. 1999 Mar 15;161(11):1621-2. Danish. No abstract available.

PMID:
10202449

Supplemental Content

Loading ...
Support Center